Skip To Voice Support Menu
For Body
For Menu
For Local Menu
Site Map
Text Size
Normal
Home
About Chugai
Group Companies
Patients
Research and Development
Careers
Contact
Chugai Pharma USA, LLC is now Chugai Pharma USA, Inc
Aug 11, 2015 Caution Regarding False Solicitations on Behalf of Chugai
May 14, 2015 Warning against Phishing e-mails and social networking sites using the name of Chugai Pharmaceutical
News Releases
What's New
24 Mar
Chugai Receives Forerunner Designation for Enspryng in Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOGAD) and Autoimmune Encephalitis (AIE)
14 Mar
Galderma Announces Updates on Nemolizumab Development
02 Mar
Chugai and Biofourmis Enter into New Partnership Focused on Data-Driven Virtual Care for Endometriosis-Related Pain
28 Feb
Chugai Files for Additional Indication of Actemra for Cytokine Release Syndrome Induced by Cancer Treatment in Japan
24 Feb
Chugai’s Anti-IL-8 Recycling Antibody AMY109, Improves Inflammation and Fibrosis in Endometriosis in an Industry-Government-Academia Non-Clinical Study Published in Science Translational Medicine
More
Videos & Advertisements
Share this site